Loading
SP
Sucampo Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Meyenburg Jason Patrick, was filed 08 Sept 2017.
Sucampo Pharmaceuticals, Inc.: what insiders have been doing
Sucampo Pharmaceuticals, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Sucampo Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 14 February 2018.
Since 2016, the database holds 2 purchases and 11 sales by insiders of the company.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
105
Thresholds
n/a
Buy Volume
€82,597
2 ops. · all time
Sell Volume
€27M
11 ops. · all time
Last declaration on 14 February 2018
Declarations105 total
600,000 shares0Class A Common StockSEC:0000899243-18-003892:0
2,000,000 shares0Class A Common StockSEC:0000899243-18-003892:1
5,406,585 shares@ US$18.00Class A Common StockSEC:0000899243-18-003892:2
2,000,000 shares0Class A Common StockSEC:0000899243-18-003897:0
5,137,344 shares@ US$18.00Class A Common StockSEC:0000899243-18-003897:1
30,228 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001100:0
6,084 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001099:0
5,139 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001101:0
263 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001102:0
24,000 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001103:0
14,930 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001108:0
5,130 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001110:0
44,856 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001104:0
5,130 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001112:0
129,729 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001106:0
5,130 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001111:0
5,130 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001105:0
36,975 shares@ US$18.00Common Stock, Class ASEC:0001171843-18-001107:0
131 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000353:0
263 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000353:1
439 shares@ US$10.24Common Stock, Class A (ESPP)SEC:0001171843-18-000344:0
660 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000176:0
171 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000179:0
329 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000178:0
330 shares@ US$9.10Common Stock, Class A (ESPP)SEC:0001171843-18-000177:0
25 of 105 declarations
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases and other medical conditions. It is listed on NASDAQ under the ticker SCMP.
